Ultrasound-guided Selective Supraclavicular Nerve Block for Postoperative Pain Control in Pediatric Patients.

• Status: Not yet recruiting
• Trial end date: 2023-07-31
• Target enrollment: 0
• Participant gender: All

Summary

This prospective randomized controlled trial aims to investigate the effect of ultrasound-guided selective supraclavicular nerve block on pain control after Hickman catheter, chemoport, or Perm cath insertion in children.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Pediatric patients receiving Hickman catheter, chemoport, or Perm cath implantation (3 years ≤, <18 years)

• One or more of the parents (or guardians), after hearing and understanding a sufficient explanation about this clinical trial, decides to participate voluntarily and agrees in writing to abide by the precautions

• In the case of a study subject aged seven years or older, a person who voluntarily decides to participate in this clinical trial and agrees in writing to abide by the precautions after hearing and understanding a sufficient explanation about this clinical trial

Exclusion Criteria:

• Patients who undergo surgery other than the surgery.

• Patients with diseases whose sensitivity to pain is different from that of the general public

• Unstable vital signs (heart rate, blood pressure)

• General contraindications of Ropivacaine

• Patients with a history of allergy to opioids

• Severe renal dysfunction (Creatinine> 3.0 mg/dl)

• Severe liver dysfunction (aspartate transaminase > 120 unit/L, alanine aminotransferase > 120 unit/L)

• Peripheral nervous system abnormalities

• At risk of malignant hyperthermia

• Other cases that the researcher judges to be inappropriate